Since radiation and anti-estrogen signaling activate p38γ (41, 42) our proof-of-concept findings from the TMA analysis suggest that p38γ-dependent CARP-1 T627 phosphorylation could be a potential predictor of responses to radiation or hormonal therapies in a subset of breast cancers. The gene discussed is CCAR1; the disease is breast cancer.